Golimumab for the Treatment of Refractory Behcet's Uveitis
Conditions: Behcet Syndrome; Uveitis Intervention: Biological: Golimumab (GOL) Sponsor: Wenjie Zheng Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 6, 2020 Category: Research Source Type: clinical trials